Ambroxol HCl is widely used as a mucolytic agent to treat respiratory conditions associated with excessive mucus production. It helps in breaking down and thinning mucus, making it easier to expel from the airways, thus improving breathing in patients with chronic bronchitis, asthma, and other obstructive pulmonary diseases. Additionally, it stimulates the production of surfactant in the lungs, further aiding respiration and reducing shortness of breath. It has been found to possess anti-inflammatory and antioxidant properties, which can aid in reducing airway inflammation and protecting lung tissue from oxidative stress. Ambroxol HCl is also used to enhance the effectiveness of antibiotics in treating respiratory infections by improving their penetration into lung tissue. In recent years, it has gained attention for its potential role in managing neurological conditions, such as Parkinson’s disease and Gaucher’s disease, due to its ability to enhance lysosomal function and reduce toxic protein buildup. It is available in various forms including tablets, oral liquid, and injections to suit different patient ages and conditions.